par Gkioulbasanis, I;Souglakos, J;Vardakis, N;Kotsakis, A;Saridaki, Z.;Kentepozidis, N;Polyzos, A;Giassas, S;Ignatiadis, Michail
;Bozionelou, V;Christophylakis, C;Georgoulias, Vassilis
Référence Journal of Balkan Union of Oncology, 12, 2, page (197-202)
Publication Publié, 2007
;Bozionelou, V;Christophylakis, C;Georgoulias, VassilisRéférence Journal of Balkan Union of Oncology, 12, 2, page (197-202)
Publication Publié, 2007
Article révisé par les pairs
| Titre: |
|
| Auteur: | Gkioulbasanis, I; Souglakos, J; Vardakis, N; Kotsakis, A; Saridaki, Z.; Kentepozidis, N; Polyzos, A; Giassas, S; Ignatiadis, Michail; Bozionelou, V; Christophylakis, C; Georgoulias, Vassilis |
| Informations sur la publication: | Journal of Balkan Union of Oncology, 12, 2, page (197-202) |
| Statut de publication: | Publié, 2007 |
| Sujet CREF: | Médecine pathologie humaine |
| Sciences bio-médicales et agricoles | |
| MeSH keywords: | Adult |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects | |
| Camptothecin -- administration & dosage -- adverse effects -- analogs & derivatives -- therapeutic use | |
| Drug Administration Schedule | |
| Female | |
| Fluorouracil -- administration & dosage -- adverse effects -- therapeutic use | |
| Gastrointestinal Neoplasms -- drug therapy | |
| Humans | |
| Leucovorin -- administration & dosage -- adverse effects -- therapeutic use | |
| Male | |
| Maximum Tolerated Dose | |
| Middle Aged | |
| Organoplatinum Compounds -- administration & dosage -- adverse effects -- therapeutic use | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1107-0625 |
| info:pmid/17600872 |



